---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-008292"
form_type: "8-K"
ticker: "VACH"
cik: "0002006815"
company_name: "Voyager Acquisition Corp./Cayman Islands"
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T03:06:54.640289+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Voyager Acquisition extends Veraxa Biotech deal deadline to Aug 7, 2026; removes SPAC termination fee

## Summary
- Amendment to Business Combination Agreement extends drop-dead date to August 7, 2026.
- SPAC Termination Fee eliminated for terminations under Section 10.1(i) (failure to close by end date).
- Termination fee of $12.5M remains payable if deal terminated due to Veraxa breach under Section 10.1(f).
- Amendment signed October 18, 2025; filed on Form 8-K on October 21, 2025.

## SEC filing metadata
- accession: 0001829126-25-008292
- form_type: 8-K
- ticker: VACH
- cik: 0002006815
- company_name: Voyager Acquisition Corp./Cayman Islands
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006815/000182912625008292/0001829126-25-008292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006815/000182912625008292/voyageracq_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-008292
- JSON: https://secwatch.observer/filing/0001829126-25-008292.json
- Plain text: https://secwatch.observer/filing/0001829126-25-008292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.